A safety evaluation of raltegravir for the treatment of HIV
R de Miguel, R Montejano… - Expert opinion on …, 2018 - Taylor & Francis
Introduction: Raltegravir (RAL) was the first commercialized agent from a new drug class
with an innovative target, the integrase. Since its introduction in clinical practice RAL has …
with an innovative target, the integrase. Since its introduction in clinical practice RAL has …
[HTML][HTML] A single-center retrospective cohort analysis of maternal and infant outcomes in HIV-infected mothers treated with integrase inhibitors during pregnancy
ML Mounce, L Pontiggia, JL Adams - Infectious diseases and therapy, 2017 - Springer
Introduction Integrase strand transfer inhibitors (INSTI) are currently being investigated for
the treatment of HIV in pregnancy. The purpose of this study is to evaluate the differences in …
the treatment of HIV in pregnancy. The purpose of this study is to evaluate the differences in …
[PDF][PDF] Sponsors and Supporters
OF Forwarder - uiphp.org.ua
On 23-26 July 2017, 6,277 HIV professionals and community members from around the
world gathered in Paris, France, for the 9th IAS Conference on HIV Science (IAS 2017). The …
world gathered in Paris, France, for the 9th IAS Conference on HIV Science (IAS 2017). The …
[引用][C] A Single-Center Retrospective Cohort Analysis of Maternal and Infant Outcomes in HIV-Infected Mothers Treated with Integrase Inhibitors During Pregnancy
MLMLP Jessica, L Adams - 2017